Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach
Metabolic Associated Fatty Liver Disease (MASLD) is a condition that is often present in patients with a history of cholecystectomy. This is because both situations share interconnected metabolic pathways. This study aimed to establish a predictive model that allows for the identification of patient...
Main Authors: | Miguel Suárez, Raquel Martínez, Ana María Torres, Antonio Ramón, Pilar Blasco, Jorge Mateo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/20/6489 |
Similar Items
-
A Machine Learning-Based Method for Detecting Liver Fibrosis
by: Miguel Suárez, et al.
Published: (2023-09-01) -
Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis
by: Jun-Hyuk Lee, et al.
Published: (2023-12-01) -
FREQUENCY OF CONVERSION TO OPEN CHOLECYSTECTOMY AMONG MALE AND FEMALE PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY
by: Sajid Rehman Randhawa, et al.
Published: (2014-06-01) -
Immunopathogenesis of liver fibrosis in steatotic liver disease
by: Chaerin Woo, et al.
Published: (2024-04-01) -
Partial Cholecystectomy: Indications and Outcomes
by: Abdul Ghani, et al.
Published: (2013-12-01)